BerGenBio ASA (OSL:BGBIO)

BerGenBio ASA Balance Sheet

Financials in millions NOK. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	140.16	156.42	150.8	436.65	721.64
Cash & Short-Term Investments	140.16	156.42	150.8	436.65	721.64
Cash Growth	-10.40%	3.72%	-65.46%	-39.49%	184.57%
Other Receivables	8.86	10.09	14.06	11.7	13.5
Receivables	8.86	10.09	14.06	11.7	13.5
Prepaid Expenses	5.53	7.39	1.8	0.7	0.73
Other Current Assets	0	0	-	0	-
Total Current Assets	154.54	173.9	166.66	449.05	735.87
Property, Plant & Equipment	1.25	0.43	0.04	1.19	2.33
Other Long-Term Assets	-0	-	-	-	-0
Total Assets	155.8	174.34	166.71	450.24	738.2
Accounts Payable	12.92	18.61	29.63	26.73	22.55
Accrued Expenses	-	27.79	48.3	37.46	43.4
Current Portion of Leases	-	0.42	-	0.68	0.65
Other Current Liabilities	19.35	0.04	-	0	-
Total Current Liabilities	32.28	46.86	77.93	64.87	66.6
Long-Term Debt	0.82	-	0.28	-	1.37
Long-Term Leases	-	-	-	0.94	-
Total Liabilities	33.1	46.86	78.21	65.81	67.97
Common Stock	39.09	268.87	8.87	8.85	8.73
Additional Paid-In Capital	8.9	0.85	35.78	335.2	628.23
Retained Earnings	22.02	-189.23	-	-	-
Comprehensive Income & Other	52.7	46.99	43.85	40.39	33.27
Shareholders' Equity	122.7	127.48	88.5	384.43	670.23
Total Liabilities & Equity	155.8	174.34	166.71	450.24	738.2
Total Debt	0.82	0.42	0.28	1.62	2.02
Net Cash (Debt)	139.34	156	150.53	435.02	719.62
Net Cash Growth	-10.68%	3.64%	-65.40%	-39.55%	184.44%
Net Cash Per Share	3.95	10.90	169.83	494.59	960.53
Filing Date Shares Outstanding	39.09	26.89	0.89	0.88	0.87
Total Common Shares Outstanding	39.09	26.89	0.89	0.88	0.87
Working Capital	122.27	127.05	88.73	384.18	669.27
Book Value Per Share	3.14	4.74	99.82	434.60	768.08
Tangible Book Value	122.7	127.48	88.5	384.43	670.23
Tangible Book Value Per Share	3.14	4.74	99.82	434.60	768.08
Machinery	-	1.73	1.73	1.77	1.77

Source: S&P Global Market Intelligence. Standard template. Financial Sources.